VENTILATOR ASSOCIATED BACTERIAL PNEUMONIA (VABP)
Clinical trials for VENTILATOR ASSOCIATED BACTERIAL PNEUMONIA (VABP) explained in plain language.
Never miss a new study
Get alerted when new VENTILATOR ASSOCIATED BACTERIAL PNEUMONIA (VABP) trials appear
Sign up with your email to follow new studies for VENTILATOR ASSOCIATED BACTERIAL PNEUMONIA (VABP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race against superbug: new drug combo enters final testing for deadly hospital pneumonia
Disease control Not yet recruitingThis study is testing a new antibiotic combination (BV100 plus polymyxin B) against a standard treatment for a severe type of pneumonia caught in hospitals. It focuses on infections caused by a bacteria that resists most antibiotics, making them very hard to treat. The main goal …
Matched conditions: VENTILATOR ASSOCIATED BACTERIAL PNEUMONIA (VABP)
Phase: PHASE3 • Sponsor: BioVersys SAS • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Fighting the superbug: new hope for patients with untreatable infections
Disease control Not yet recruitingThis study is testing a new antibiotic combination called BV100 for patients with severe hospital-acquired infections caused by a dangerous, drug-resistant bacteria. It will compare BV100 combined with other antibiotics against the current best available treatments. The goal is t…
Matched conditions: VENTILATOR ASSOCIATED BACTERIAL PNEUMONIA (VABP)
Phase: PHASE2 • Sponsor: BioVersys AG • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC